Amivantamab in Participants with Advanced Non-small Cell Lung Cancer (NSCLC) and MET Exon 14 Skipping Mutations: Final Results from the CHRYSALIS Study.

Matthew G Krebs,Byoung Chul Cho,Sandrine Hiret, Ji-Youn Han,Ki Hyeong Lee,Casilda Llácer Pérez, Filippo De Braud, Eric B Haura, Rachel E Sanborn,James Chih-Hsin Yang,Catherine A Shu,Koichi Goto,Makoto Nishio,Jun Zhao,Zhijie Wang,Pascale Tomasini,Enriqueta Felip, Jonathan W Goldman, Sai-Hong Ignatius Ou,Michael Boyer, Grace Gao, Siyang Qu, Joshua C Curtin, Xuesong Lyu,Robert W Schnepp, Priya Kim,Meena Thayu, Roland E Knoblauch, Patricia Lorenzini, Mahadi Baig,Alexander I Spira, Natasha B Leighl

Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer（2025）

Cited 0|Views3

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined